Profile change history

What changed for GHRP-2?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed GHRP-2 identity.

22Total events
21Record additions
1Version changes
7Cited source years

Before and after

Preserved version changes

Profile updated

GHRP-2 profile

We added FDA’s May 2026 503A nominations list, which places GHRP-2 in category 3, and two human studies of its effect on growth hormone and appetite and its use as a diagnostic test.

PeptideScanner change date
November 16, 2026
Evidence lane
Profile

Evidence note

Before
FDA reports serious adverse events in patients who received GHRP-2, with causality not established. No FDA approval is reported in the cited sources, and GHRP-2 is not among the six peptides in HHS’s October 2026 draft enforcement-discretion policy.
After
Small human studies report that GHRP-2 raises growth hormone and appetite, and test it as a diagnostic. FDA reports serious adverse events in patients who received GHRP-2, with causality not established. No FDA approval is reported, and GHRP-2 is not among the six peptides in HHS’s October 2026 draft enforcement-discretion policy.

Cited source records

Before
fda-ghrp-2-identity, fda-bulk-peptide-risks, hhs-503a-peptide-enforcement-discretion-notice-2026, hhs-503a-peptide-enforcement-discretion-policy-2026
After
fda-ghrp-2-identity, fda-bulk-peptide-risks, hhs-503a-peptide-enforcement-discretion-notice-2026, hhs-503a-peptide-enforcement-discretion-policy-2026, fda-503a-nominations-2026-05-14, journal-pmid-17609397, journal-pmid-16861611

Claim citations

Before
name: fda-ghrp-2-identity, fda-bulk-peptide-risks; aliases: fda-ghrp-2-identity; category: fda-bulk-peptide-risks; status: fda-bulk-peptide-risks; summary: fda-ghrp-2-identity, fda-bulk-peptide-risks; evidenceNote: fda-bulk-peptide-risks, hhs-503a-peptide-enforcement-discretion-policy-2026
After
name: fda-ghrp-2-identity, fda-bulk-peptide-risks; aliases: fda-ghrp-2-identity; category: fda-bulk-peptide-risks; status: fda-bulk-peptide-risks; summary: fda-ghrp-2-identity, fda-bulk-peptide-risks; evidenceNote: journal-pmid-16861611, journal-pmid-17609397, fda-bulk-peptide-risks, hhs-503a-peptide-enforcement-discretion-policy-2026

Collection chronology

Evidence added to PeptideScanner

Browse all 21 connected records →

Showing the latest 21 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 15, 2026.

Record added

Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans.

PubMed lists PMID 10195374 in Journal of endocrinological investigation as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1999-02 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 13, 2018
Evidence lane
Literature metadata
Record added

Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN.

PubMed lists PMID 15230633 in Drugs in R&D as Journal Article, Review, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 25, 2018
Evidence lane
Literature metadata
Record added

Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.

PubMed lists PMID 15646370 in Arzneimittel-Forschung as Journal Article, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 24, 2016
Evidence lane
Literature metadata
Record added

General pharmacology of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.

PubMed lists PMID 15646371 in Arzneimittel-Forschung as Journal Article, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 24, 2016
Evidence lane
Literature metadata
Record added

Physiologically based pharmacokinetic model for pralmorelin hydrochloride in rats.

PubMed lists PMID 16033952 in Drug metabolism and disposition: the biological fate of chemicals as Journal Article, with publication-date metadata of 2005-07-20 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
February 12, 2025
Evidence lane
Literature metadata
Record added

Validation of growth-hormone-releasing peptide 2 for the diagnosis of adult growth hormone deficiency.

PubMed lists PMID 17971793 in Nature clinical practice. Endocrinology & metabolism as Journal Article, with publication-date metadata of 2007-10-30 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 23, 2008
Evidence lane
Literature metadata
Record added

Diagnostic usefulness of the growth hormone-releasing peptide-2 test as a substitute for the insulin tolerance test in hypopituitarism.

PubMed lists PMID 18493103 in Endocrine journal as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-05-21 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 7, 2019
Evidence lane
Literature metadata
Record added

Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study.

PubMed lists PMID 20045717 in Peptides as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-01-05 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
March 21, 2022
Evidence lane
Literature metadata
Record added

Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry.

PubMed lists PMID 20552695 in Rapid communications in mass spectrometry : RCM as Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-07-30 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 10, 2019
Evidence lane
Literature metadata
Record added

Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement.

PubMed lists PMID 20878896 in Drug testing and analysis as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-03 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 25, 2016
Evidence lane
Literature metadata
Record added

Identification and quantification of the doping agent GHRP-2 in seized unlabelled vials by NMR and MS: a case-report.

PubMed lists PMID 24446112 in Drug testing and analysis as Letter, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-01-20 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 10, 2019
Evidence lane
Literature metadata
Record added

Synthesis of Mono-PEGylated Growth Hormone Releasing Peptide-2 and Investigation of its Biological Activity.

PubMed lists PMID 25761386 in AAPS PharmSciTech as Journal Article, with publication-date metadata of 2015-03-12 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 2, 2018
Evidence lane
Literature metadata
Record added

Detection of GHRP-2 and GHRP-6 in urine samples from athletes.

PubMed lists PMID 25809000 in Drug testing and analysis as Journal Article, with publication-date metadata of 2015-03-25 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 25, 2016
Evidence lane
Literature metadata
Record added

Investigation of the clinical significance of the growth hormone-releasing peptide-2 test for the diagnosis of secondary adrenal failure.

PubMed lists PMID 27020037 in Endocrine journal as Controlled Clinical Trial, Journal Article, with publication-date metadata of 2016-03-26 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
March 21, 2022
Evidence lane
Literature metadata
Record added

On the road of dried blood spot sampling for antidoping tests: Detection of GHRP-2 abuse.

PubMed lists PMID 33197153 in Drug testing and analysis as Journal Article, Validation Study, with publication-date metadata of 2020-11-25 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 28, 2021
Evidence lane
Literature metadata
Record added

Clinical Usefulness of the Growth Hormone-Releasing Peptide-2 Test for Hypothalamic-Pituitary Disorder.

PubMed lists PMID 35795807 in Journal of the Endocrine Society as Journal Article, with publication-date metadata of 2022-06-06 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 16, 2022
Evidence lane
Literature metadata
Record added

Characteristics of growth hormone secretion responsiveness to growth hormone-releasing peptide-2 (GHRP-2 or KP102) in calves.

PubMed lists PMID 8886623 in Endocrine journal as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1996-06 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 5, 2019
Evidence lane
Literature metadata
Record added

Growth hormone releasing peptides: a comparison of the growth hormone releasing activities of GHRP-2 and GHRP-6 in rat primary pituitary cells.

PubMed lists PMID 9096259 in Life sciences as Comparative Study, Journal Article, with publication-date metadata of 1997 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 1, 2019
Evidence lane
Literature metadata
Record added

Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in children.

PubMed lists PMID 9543135 in The Journal of clinical endocrinology and metabolism as Clinical Trial, Clinical Trial, Phase I, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., with publication-date metadata of 1998-04 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 24, 2016
Evidence lane
Literature metadata
Record added

[Activity of growth hormone-releasing peptide-2 in cultured cells of human pituitary adenoma and its interaction with growth hormone-releasing hormone and somatostatin].

PubMed lists PMID 9559140 in Biulleten' eksperimental'noi biologii i meditsiny as Journal Article, with publication-date metadata of 1998-02 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2018
Evidence lane
Literature metadata
Record added

Growth hormone-releasing peptide-2 (GHRP-2) does not act via the human growth hormone-releasing factor receptor in GC cells.

PubMed lists PMID 9798733 in Endocrine as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1998-08 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 16, 2022
Evidence lane
Literature metadata